{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:37:39Z","timestamp":1761489459919},"publisher-location":"Chichester, UK","reference-count":73,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd011018.pub2","type":"reference-entry","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T19:04:34Z","timestamp":1411671874000},"source":"Crossref","is-referenced-by-count":12,"title":["Interventions for the management of oral ulcers in Beh\u00e7et's disease"],"prefix":"10.1002","author":[{"given":"Jennifer","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Glenny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Brocklehurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Gorodkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael N","family":"Pemberton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD011018.pub2-BIB1|cit1","first-page":"399","article-title":"A double blind study of colchicine in Beh\u00e7et's disease","volume":"65","author":"Aktulga","year":"1980","journal-title":"Haematologica"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archderm.135.5.529","article-title":"The use of sucralfate suspension in the treatment of oral and genital ulceration of Behcet disease: a randomized, placebo-controlled, double-blind study","volume":"135","author":"Alpsoy","year":"1999","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD011018.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archderm.138.4.467","article-title":"Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study","volume":"138","author":"Alpsoy","year":"2002","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD011018.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/rheumatology\/27.4.300","article-title":"Treatment with acyclovir does not affect orogenital ulcers in Behcet's syndrome: a randomized double-blind trial","volume":"27","author":"Davies","year":"1988","journal-title":"British Journal of Rheumatology"},{"issue":"9","key":"10.1002\/14651858.CD011018.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-4362.1997.tb03133.x","article-title":"Topical cyclosporine-A for treatment of oral ulcers of Behcet's syndrome [letter]","volume":"36","author":"Ergun","year":"1997","journal-title":"International Journal of Dermatology"},{"issue":"2","key":"10.1002\/14651858.CD011018.pub2-BIB6|cit6","first-page":"74","article-title":"Comparing the effect of phenytoin syrup and triamcinolone acetonide ointment on aphthous ulcers in patients with Behcet's syndrome","volume":"14","author":"Fani","year":"2012","journal-title":"Iranian Red Crescent Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/rheumatology\/30.5.395-a","article-title":"Inefficacy of topical alpha interferon in the treatment of oral ulcers of Behcet's syndrome: a randomized, double blind trial","volume":"30","author":"Hamuryudan","year":"1991","journal-title":"British Journal of Rheumatology"},{"key":"10.1002\/14651858.CD011018.pub2-BIB8|cit8","first-page":"443","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial","volume":"6","author":"Hamuryudan","year":"1998","journal-title":"Annals of Internal Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011018.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/rheumatology\/kep237","article-title":"Low-dose natural human interferon-alpha lozenges in the treatment of Behcet's syndrome","volume":"48","author":"Kilic","year":"2009","journal-title":"Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD011018.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/09546639209088723","article-title":"Topical sucralfate therapy for oral ulcers in Behcet's disease: a randomized double-blind study","volume":"3","author":"Koc","year":"1992","journal-title":"Journal of Dermatological Treatment"},{"key":"10.1002\/14651858.CD011018.pub2-BIB11|cit11","first-page":"437","article-title":"Ciclosporin treatment for Behcet's disease - double-masked group comparative study","volume":"14","author":"Masuda","year":"1989","journal-title":"Rinsho Hyoka"},{"issue":"8647","key":"10.1002\/14651858.CD011018.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(89)92381-7","article-title":"Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease","volume":"1","author":"Masuda","year":"1989","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD011018.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/rheumatology\/kei165","article-title":"A double-blind trial of depot corticosteroids in Beh\u00e7et's syndrome","volume":"45","author":"Mat","year":"2006","journal-title":"Rheumatology (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD011018.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00126839-200304010-00002","article-title":"Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behcet's disease: A randomised, double-blind, placebo-controlled study","volume":"4","author":"Matsuda","year":"2003","journal-title":"Drugs in R&D"},{"issue":"1","key":"10.1002\/14651858.CD011018.pub2-BIB15|cit15","first-page":"98","article-title":"Short-term trial of etanercept in Behcet's disease: a double blind, placebo controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"Journal of Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD011018.pub2-BIB16|cit16","first-page":"2686","article-title":"A double-blind trial of colchicine in Beh\u00e7et's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis and Rheumatism"},{"issue":"37","key":"10.1002\/14651858.CD011018.pub2-BIB17|cit17","first-page":"131","article-title":"Thalidomide: new preparation, for well-defined indications","volume":"7","author":"Anonymous","year":"1988","journal-title":"Prescrire International"},{"issue":"7","key":"10.1002\/14651858.CD011018.pub2-BIB18|cit18","first-page":"428","article-title":"Results of acyclovir treatment in Behcet's disease","volume":"14","author":"Azizlerli","year":"1995","journal-title":"Nouvelles Dermatologiques"},{"issue":"8","key":"10.1002\/14651858.CD011018.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1468-3083.2006.01677.x","article-title":"Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behcet's disease","volume":"20","author":"Bacanli","year":"2006","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"2","key":"10.1002\/14651858.CD011018.pub2-BIB20|cit20","first-page":"128","article-title":"[Colchicine]","volume":"103","author":"Ben Slama","year":"2002","journal-title":"Revue de Stomatologie et de Chirurgie Maxillo-faciale"},{"issue":"2","key":"10.1002\/14651858.CD011018.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000246336","article-title":"Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behcet's disease","volume":"192","author":"Calguneri","year":"1996","journal-title":"Dermatology (Basel, Switzerland)"},{"issue":"3","key":"10.1002\/14651858.CD011018.pub2-BIB22|cit22","first-page":"253","article-title":"Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial","volume":"13","author":"Chams-Davatchi","year":"2010","journal-title":"International Journal of Rheumatic Diseases"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2133.1984.tb06638.x","article-title":"Effectiveness of dapsone in Behcet's disease","volume":"111","author":"Convit","year":"1984","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/s10165-009-0200-2","article-title":"Colchicine versus placebo in Behcet's disease: randomized, double-blind, controlled crossover trial","volume":"19","author":"Davatchi","year":"2009","journal-title":"Modern Rheumatology \/ the Japan Rheumatism Association"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1468-3083.2007.02564.x","article-title":"Hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behcet's disease","volume":"22","author":"Lee","year":"2008","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"issue":"6","key":"10.1002\/14651858.CD011018.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2165\/0126839-200809060-00008","article-title":"Irsogladine is effective for recurrent oral ulcers in patients with Behcet's disease: an open-label, single-centre study","volume":"9","author":"Nanke","year":"2008","journal-title":"Drugs in R&D"},{"key":"10.1002\/14651858.CD011018.pub2-BIB27|cit27","unstructured":"NCT01211977 A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome (FCAS) \/ Muckle-Wells Syndrome (MWS) and Behcet's Disease (BD) http:\/\/clinicaltrials.gov\/show\/NCT01211977"},{"key":"10.1002\/14651858.CD011018.pub2-BIB28|cit28","article-title":"A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Mucocutaneous Manifestations of Behcet's Syndrome","author":"NCT01693640","journal-title":"http:\/\/clinicaltrials.gov\/show\/NCT01693640"},{"key":"10.1002\/14651858.CD011018.pub2-BIB29|cit29","unstructured":"NCT01693653 Tocilizumab for the Treatment of Behcet's Syndrome http:\/\/clinicaltrials.gov\/show\/NCT01693653"},{"issue":"10","key":"10.1002\/14651858.CD011018.pub2-BIB30|cit30","first-page":"1938","article-title":"Interferon-alpha treatment of Behcet's disease","volume":"25","author":"O'Duffy","year":"1998","journal-title":"Journal of Rheumatology"},{"issue":"17","key":"10.1002\/14651858.CD011018.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0025-7753(00)71659-9","article-title":"[Pentoxifylline in the treatment of orogenital aphthosis and Behcet's syndrome]","volume":"115","author":"Pizarro","journal-title":"Medicina Clinica"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB32|cit32","first-page":"733","article-title":"Treatment of recurrent oral aphthous ulcers with etanercept","volume":"20","author":"Scheinberg","year":"2002","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1346-8138.2002.tb00263.x","article-title":"Dapsone in Beh\u00e7et's disease: a double-blind, placebo-controlled, cross-over study","volume":"29","author":"Sharquie","year":"2002","journal-title":"Journal of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD011018.pub2-BIB34|cit34","first-page":"68","article-title":"The therapeutic role of isotretinoin in the management of Beh\u00e7et's disease: a single-blinded, controlled therapeutic study","volume":"12","author":"Sharquie","year":"2013","journal-title":"Journal of Drugs in Dermatology"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1600-0714.2009.00774.x","article-title":"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease","volume":"38","author":"Sun","year":"2009","journal-title":"Journal of Oral Pathology & Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011018.pub2-BIB37|cit37","unstructured":"NCT00866359 A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Followed by an Active-Treatment Extension to Evaluate the Efficacy and Safety of Apremilast(CC-10004) in the Treatment of Beh\u00e7et Disease http:\/\/clinicaltrials.gov\/show\/NCT00866359"},{"key":"10.1002\/14651858.CD011018.pub2-BIB38|cit38","unstructured":"NCT01441076 A Pilot Study of Anakinra in Behcet's Disease (BD) http:\/\/clinicaltrials.gov\/show\/NCT01441076"},{"issue":"8","key":"10.1002\/14651858.CD011018.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1601-0825.2011.01840.x","article-title":"Urban legends: recurrent aphthous stomatitis","volume":"17","author":"Baccaglini","year":"2011","journal-title":"Oral Diseases"},{"issue":"2","key":"10.1002\/14651858.CD011018.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jebdp.2013.04.012","article-title":"There is limited evidence that topical lavender oil is effective for palliative treatment of recurrent aphthous stomatitis","volume":"13","author":"Baccaglini","year":"2013","journal-title":"The Journal of Evidence-Based Dental Practice"},{"issue":"8","key":"10.1002\/14651858.CD011018.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0714.1991.tb00952.x","article-title":"Recurrent aphthous stomatitis. A study of the clinical characteristics of lesions in 93 cases","volume":"20","author":"Bagan","year":"1991","journal-title":"Journal of Oral Pathology & Medicine"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0248-8663(05)80843-4","article-title":"Behcet's disease and desensitization by autologous saliva","volume":"12","author":"Benamour","year":"1991","journal-title":"Revue de Medecine Interne"},{"issue":"9","key":"10.1002\/14651858.CD011018.pub2-BIB43|cit43","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005411.pub2","article-title":"Systemic interventions for recurrent aphthous stomatitis (mouth ulcers)","author":"Brocklehurst","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011018.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1756-185X.2010.01531.x","article-title":"Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial","volume":"13","author":"Chams-Davatchi","year":"2010","journal-title":"International Journal of Rheumatic Diseases"},{"issue":"17","key":"10.1002\/14651858.CD011018.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2165\/11641370-000000000-00000","article-title":"Beh\u00e7et's Syndrome","volume":"72","author":"Dalvi","year":"2012","journal-title":"Drugs"},{"issue":"2","key":"10.1002\/14651858.CD011018.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1479-8077.2004.00074.x","article-title":"New and innovative therapies for Beh\u00e7et's disease","volume":"7","author":"Davatchi","year":"2004","journal-title":"APLAR Journal of Rheumatology"},{"key":"10.1002\/14651858.CD011018.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2012\/607921","article-title":"Diagnosis\/Classification Criteria for Behcet's Disease","volume":"2012","author":"Davatchi","year":"2012","journal-title":"Pathology Research International"},{"key":"10.1002\/14651858.CD011018.pub2-BIB48|cit48","first-page":"201","article-title":"Selecting topical and systemic agents for recurrent aphthous stomatitis","volume":"68","author":"Eisen","year":"2001","journal-title":"Cutis"},{"issue":"1","key":"10.1002\/14651858.CD011018.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011018.pub2-BIB50|cit50","unstructured":"GRADEpro Version 3.2 for Windows. Jan Brozek, Andrew Oxman, Holger Sch\u00fcnemann, 2008"},{"issue":"14","key":"10.1002\/14651858.CD011018.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2165\/00003495-200767140-00004","article-title":"Standard and novel therapeutic approaches to Behcet's disease","volume":"67","author":"Gul","year":"2007","journal-title":"Drugs"},{"issue":"6","key":"10.1002\/14651858.CD011018.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Beh\u00e7et syndrome. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011018.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Behcet's disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011018.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3899\/jrheum.131249","article-title":"Outcome measures used in clinical trials for Behcet's syndrome: a systematic review","volume":"41","author":"Hatemi","year":"2014","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD011018.pub2-BIB55|cit55","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD011018.pub2-BIB56|cit56","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et\u2019s disease","volume":"335","year":"1990","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD011018.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1601-0825.2005.01143.x","article-title":"Mucosal disease series. Number VI. Recurrent aphthous stomatitis","volume":"12","author":"Jurge","year":"2006","journal-title":"Oral Diseases"},{"key":"10.1002\/14651858.CD011018.pub2-BIB58|cit58","first-page":"7 pages","article-title":"Development of immunopathogenesis strategies to treat Beh\u00e7et's disease","volume":"Article ID: 261","author":"Kose","year":"2012","journal-title":"Pathology Research International"},{"issue":"4","key":"10.1002\/14651858.CD011018.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.clindermatol.2013.01.002","article-title":"Behcet's syndrome: facts and controversies","volume":"31","author":"Mat","year":"2013","journal-title":"Clinics in Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD011018.pub2-BIB60|cit60","first-page":"98","article-title":"Short-term trial of etanercept in Beh\u00e7et's disease: a double blind, placebo controlled study","volume":"32","author":"Melikoglu","year":"2005","journal-title":"Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD011018.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/10454411980090030401","article-title":"Recurrent aphthous stomatitis","volume":"9","author":"Porter","year":"1998","journal-title":"Current Reviews in Oral Biology and Medicine"},{"key":"10.1002\/14651858.CD011018.pub2-BIB62|cit62","unstructured":"Review Manager (RevMan) [Computer program] Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012"},{"issue":"3","key":"10.1002\/14651858.CD011018.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1601-0825.2010.01734.x","article-title":"Impact of chronic oral mucosal disease on daily life: preliminary observations from a qualitative study","volume":"17","author":"Riordain","year":"2011","journal-title":"Oral Diseases"},{"issue":"Issue 2","key":"10.1002\/14651858.CD011018.pub2-BIB64|cit64","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001084","article-title":"Pharmacotherapy for Behcet's syndrome","author":"Saenz","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011018.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMcp054630","article-title":"Clinical practice. Aphthous ulceration","volume":"355","author":"Scully","year":"2006","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD011018.pub2-BIB66|cit66","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010881","article-title":"Topical interventions for recurrent aphthous stomatitis (mouth ulcers)","author":"Taylor","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011018.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/archderm.143.4.463","article-title":"A randomized, double-blind, placebo-controlled trial of pentoxifylline for the treatment of recurrent aphthous stomatitis","volume":"143","author":"Thornhill","year":"2007","journal-title":"Archives of Dermatology"},{"issue":"4","key":"10.1002\/14651858.CD011018.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/ard.39.4.344","article-title":"HLA antigens in Beh\u00e7et's disease: a reappraisal by a comparative study of Turkish and British patients","volume":"39","author":"Yazici","year":"1980","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD011018.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Beh\u00e7et's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011018.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","article-title":"Beh\u00e7et syndrome: is it one condition?","volume":"43","author":"Yazici","year":"2012","journal-title":"Clinical Reviews in Allergy and Immunology"},{"issue":"11","key":"10.1002\/14651858.CD011018.pub2-BIB71|cit71","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Beh\u00e7et's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD011018.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.berh.2008.08.005","article-title":"Beh\u00e7et\u2019s syndrome","volume":"22","author":"Yurdakul","year":"2008","journal-title":"Best Practice and Research. Clinical Rheumatology"},{"key":"10.1002\/14651858.CD011018.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-4419-5641-5_3","article-title":"Epidemiology of Beh\u00e7et's syndrome and regional differences in disease expression","volume-title":"Beh\u00e7et's Syndrome","author":"Yurdakul","year":"2010"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T08:24:54Z","timestamp":1625041494000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/14651858.CD011018.pub2"}},"subtitle":[],"editor":[{"given":"Jennifer","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":73,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011018.pub2","relation":{},"subject":[],"published":{"date-parts":[[2014,9,25]]}}}